Clinical trial Recruiting at 1 site Interventional Ages 20 to 40

Comparing agility training with and without foot mobilization for patellofemoral pain syndrome

Official title: Effects of Agility Training With and Without Foot Mobilization On Pain, Balance and Functional Performance In Patellofemoral Pain Syndrome.

Run by Riphah International University · NCT06674707 · Data updated 2026-11-12

This study is testing whether adding foot mobilization to agility training can help young adults with patellofemoral pain syndrome feel better and move more easily.

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexAll
Enrollment42 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedJanuary 4, 2024
Main results expectedJanuary 7, 2025
Study endsJanuary 7, 2025
Registry record updatedNovember 5, 2024
Trial IDNCT06674707 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 20-40 who have been experiencing symptoms of patellofemoral pain syndrome for more than six months.

Probably not a fit

Patients with a history of ligament or meniscal injuries, lower limb fractures, or systemic conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of agility training combined with foot mobilization versus agility training alone on patients suffering from patellofemoral pain syndrome (PFPS). A total of 42 participants aged 20-40 will be randomly assigned to two groups: one receiving both agility training and foot mobilization, and the other receiving only agility training. The interventions will take place three times a week for six weeks, with outcomes measured through pain scales and functional performance tests before and after the intervention period. Data analysis will be conducted using SPSS software to assess the effectiveness of the treatments.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment approach for alleviating pain and improving function in patients with patellofemoral pain syndrome.

How similar studies have gone: While there is limited data on the specific combination of agility training and foot mobilization, similar interventions have shown promise in improving outcomes for patients with musculoskeletal conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Clinical signs of patellofemoral pain syndrome such as retro patellar pain, crepitation, and pain with patellar grinding more than 6 months.

* Both genders of 20-40 years of age.
* Presence of pain on step down from a 25 step or double leg squat and sitting with knee bent greater than 15 min.
* Pain more than 4 on NPRS scale.
* Individual with anterior left/right asymmetries greater than 4 cm on Y balance test
* Excessive calcaneal eversion measured at 6° in the relaxed posture(6).

Exclusion Criteria:

* History of ligament and meniscal injury.
* History of lower limb fractures.
* History of post-surgical condition of lower limb
* History of systemic, connective tissue or neurologic condition

Where it's running

  • Al- Rehman Hospital
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.